ESR1 and breast cancer: These findings highlight an essential role of MOF in modulating ER signaling in BC and rationalize MOF as a potential therapeutic target, like developing specific MOF activator for anti-ER treatment in ERα+ BC or combination therapy of MG149 with TAM for resistance amelioration in ERα− BC.